Información del artículo
Resumen
Introducción
Los pacientes en diálisis frecuentemente presentan problemas de sueño que afectan su funcionamiento global.
ObjetivoPresentar una revisión actualizada de la literatura médica acerca de los trastornos del sueño en pacientes en diálisis por enfermedad renal crónica.
MétodoSe revisaron los artículos publicados recientemente sobre el tema, buscando establecer asociaciones, mecanismos fisiopatológicos y recomendaciones de manejo.
Resultados y conclusiónLos trastornos del sueño son problemas clínicos frecuentes en los pacientes en diálisis por enfermedad renal crónica que impactan negativamente la calidad de vida y la salud de quienes los padecen y que necesitan ser reconocidos apropiadamente por los equipos médicos que atienden estos pacientes.
Palabras clave:
trastornos del sueño
diálisis
fallo renal crónico
calidad de vida
Abstract
Introduction
Sleep disorders are very common in dialysis patients. The most common problems are insomnia, restless legs syndrome, sleep apnea, periodic limb movements, and excessive daytime sleepiness.
ObjectiveTo present an updated review of the medical literature on sleep disorders in patients on dialysis for chronic kidney disease.
MethodsWe reviewed recent articles published on the topic, seeking partnerships, pathophysiologic mechanisms, and treatment recommendations.
Results and ConclusionSleep disorders are common clinical problems in patients on dialysis for chronic kidney disease that negatively impact the quality of life and health of those who suffer from them. They need to be properly diagnosed by the medical teams treating these patients.
Key words:
Sleep disorders
dialysis
kidney failure
chronic
quality of life
El Texto completo está disponible en PDF
Referencias
[1]
C López, H Altahona.
Proyección de pacientes con diálisis crónica 1985-2010.
Periódico El Pulso, 6 (2005),
[2]
HE Reichenmiller, U Reinhard, F Dürr.
Sleep EEG and uraemia.
Electroencephalogr Clin Neurophysiol, 30 (1971), pp. 263-264
[3]
NK Wadgwa, M Seliger, HE Greenberg, E Bergofsky, WB Mendelson.
Sleep related respiratory disorders in end-stage renal disease patients on peritoneal dialysis.
Perit Dial Int, 12 (1992), pp. 51-56
[4]
SD Weisbord, LF Fried, MK Mor, AL Resnick, ML Unruh, PM Palevsky, et al.
Renal provider recognition of symptoms in patients on maintenance hemodialysis.
Clin J Am Soc Nephrol, 2 (2007), pp. 960-967
[5]
G Merlino, A Piani, P Dolso, M Adorati, I Cancelli, M Valente, et al.
Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy.
Nephrol Dial Transplant, 21 (2006), pp. 184-190
[6]
V Liakopoulos, I Stefanidis, T Eleftheriadis, CG Musso, I Ioannidis, DG Oreopoulos.
Age and underdialysis as predictors of sleep disorders in peritoneal dialysis patients.
Int Urol Nephrol, 38 (2006), pp. 359-360
[7]
J Perl, ML Unruh, CT Chan.
Sleep disorders in end-stage renal disease: Markers of inadequate dialysis'?.
Kidney Int, 70 (2006), pp. 1687-1693
[8]
B Strub, D Schneider-Helmert, F Gnirss, A Blumberg.
Sleep disorders in patients with chronic renal insufficiency in long-term hemodialysis treatment.
Schweiz Med Wochenschr, 112 (1981), pp. 824-828
[9]
JL Holley, S Nespor, R Rault.
Characterizing sleep disorders in chronic hemodialysis patients.
ASAIO Trans, 37 (1991), pp. M456-M457
[10]
WB Mendelson, NK Wadhwa, HE Greenberg, K Guyavarty, E Bergofsky.
Effects of hemodialysis on sleep apnea syndrome in end-stage renal disease.
Clin Nephrol, 33 (1990), pp. 247-1990
[12]
NG Kutner, DL Bliwise, D Brogan, R Zhang.
Race and restless sleep complaint in older chronic dialysis patients and non-dialysis community controls.
J Gerontol B Psychol Sci Soc Sci, 56 (2001), pp. P170-P175
[13]
K Parker.
Dream content and subjective sleep quality in stable patients on chronic dialysis.
ANNA J, 23 (1996), pp. 201-210
[14]
RW Evans, B Rader, DL Manninen.
The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group.
JAMA, 263 (1990), pp. 825-830
[15]
G Virga, L Stanic, S Mastrosimone, F Gastaldon, A da Porto, A Bonadonna.
Hypercalcemia and insomnia in hemodialysis patients.
Nephron, 85 (2000), pp. 94-95
[16]
AE Molzahn, HC Northcott, JB Dossetor.
Quality of life of individuals with end stage renal disease: perceptions of patients, nurses, and physicians.
ANNA J, 24 (1997), pp. 325-333
[17]
S Walker, A Fine, MH Kryger.
Sleep complaints are common in a dialysis unit.
Am J Kidney Dis, 26 (1995), pp. 751-756
[18]
MF Pai, SP Hsu, SY Yang, TI Ho, CF Lai, YS Peng.
Sleep disturbance in chronic hemodialysis patients: the impact of depression and anemia.
Ren Fail, 29 (2007), pp. 673-677
[19]
ML Unruh, DJ Buysse, MA Dew, IV Evans, AW Wu, NE Fink, et al.
Sleep quality and its correlates in the first year of dialysis.
Clin J Am Soc Nephrol, 1 (2006), pp. 802-810
[20]
SJ Elder, RL Pisoni, T Akizawa, R Fissell, VE Andreucci, S Fukuhara, et al.
Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Nephrol Dial Transplant, 23 (2008), pp. 998-1004
[21]
A Noda, S Nakai, T Soga, T Sugiura, N Iwayama, K Maeda, et al.
Factors contributing to sleep disturbance and hypnotic drug use in hemodialysis patients.
Intern Med, 45 (2006), pp. 1273-1278
[22]
HY Chen, CK Chiang, HH Wang, KY Hung, YJ Lee, YS Peng, et al.
Cognitive–behavioral therapy for sleep disturbance in patients undergoing peritoneal dialysis: a pilot randomized controlled trial.
Am J Kidney Dis, 52 (2008), pp. 314-323
[23]
E Stepanski, M Faber, F Zorick, R Basner, T Roth.
Sleep disorders in patients on continuous ambulatory peritoneal dialysis.
J Am Soc Nephrol, 6 (1995), pp. 192-197
[24]
S Walker, A Fine, MH Kryger.
Sleep complaints are common in a dialysis unit.
Am J Kidney Dis, 26 (1995), pp. 751-756
[25]
P Hanly.
Sleep disorders and end-stage renal disease.
Curr Opin Pulm Med, 14 (2008), pp. 543-550
[26]
KP Parker, DL Bliwise, JL Bailey, DB Rye.
Daytime sleepiness in stable hemodialysis patients.
Am J Kidney Dis, 41 (2003), pp. 394-402
[27]
American Academy of Sleep Medicine.
The International Classification of Sleep Disorders, American Sleep Disorders Association, (1997),
[28]
American Academy of Sleep Medicine.
The international classification of sleep disorders. Diagnostic and coding manual, 2nd ed., pp. 178-187
[29]
ML Unruh, AS Levey, C D'Ambrosio, NE Fink, NR Powe, KB Meyer, et al.
Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival.
Am J Kidney Dis, 43 (2004), pp. 900-909
[30]
J Takaki, T Nishi, M Nangaku, H Shimoyama, T Inada, N Matsuyama, et al.
Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis.
Am J Kidney Dis, 41 (2003), pp. 833-839
[31]
GL Gigli, M Adorati, P Dolso, A Piani, M Valente, S Brotini, et al.
Restless legs syndrome in end-stage renal disease.
Sleep Med, 5 (2004), pp. 309-315
[32]
RL Benz, MR Pressman, ET Hovick, DD Peterson.
A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study).
Am J Kidney Dis, 34 (1999), pp. 1089-1095
[33]
JA Sloand, MA Shelly, A Feigin, P Bernstein, RD Monk.
A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome.
Am J Kidney Dis, 43 (2004), pp. 663-670
[34]
RL Benz, MR Pressman, ET Hovick, DD Peterson.
Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders.
Am J Kidney Dis, 35 (2000), pp. 1052-1060
[35]
NJ Ali, RJ Davies, JA Fleetham, JR Stradling.
Periodic movements of the legs during sleep associated with rises in systemic blood pressure.
Sleep, 14 (1991), pp. 163-165
[36]
C Trenkwalder, K Stiasny, T Pollmacher, T Wetter, J Schwarz, R Kohnen, et al.
L-Dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial.
Sleep, 18 (1995), pp. 681-688
[37]
J Pieta, T Millar, J Zacharias, A Fine, M Kryger.
Effect of pergolide on restless legs and leg movements in sleep in uremic patients.
Sleep, 21 (1998), pp. 617-622
[38]
M Miranda, M Kagi, L Fabres, L Aguilera, M Alvo, L Elgueta, et al.
Pramipexole for the treatment of uremic restless legs in patients undergoing hemodialysis.
Neurology, 62 (2004), pp. 831-832
[39]
MT Pellecchia, C Vitale, M Sabatini, K Longo, M Amboni, V Bonavita, et al.
Ropinirole as a treatment of restless legs syndrome in patients on chronic hemodialysis: an open randomized crossover trial versus levodopa sustained release.
Clin Neuropharmacol, 27 (2004), pp. 178-181
[40]
E Stepanski, M Faber, F Zorick, R Basner, T Roth.
Sleep disorders inpatients on continuous ambulatory peritoneal dialysis.
J Am Soc Nephrol, 6 (1995), pp. 192-197
[41]
PL Kimmel, G Miller, WB Mendelson.
Sleep apnea syndrome in chronic renal disease.
Am J Med, 86 (1989), pp. 308-314
[42]
NK Wadhwa, WB Mendelson.
A comparison of sleep-disordered respiration in ESRD patients receiving hemodialysis and peritoneal dialysis.
Adv Perit Dial, 8 (1992), pp. 195-198
[43]
ML Unruh, MH Sanders, S Redline, BM Piraino, JG Umans, TC Hammond, et al.
Sleep apnea in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the Sleep Heart Health Study.
J Am Soc Nephrol, 17 (2006), pp. 3503-3509
[44]
J Beecroft, A Pierratos, P Hanly.
Clinical presentation of obstructive sleep apnea in patients with end-stage renal disease.
Am J Respir Crit Care Med, 117 (2008), pp. A937
[45]
SD Weisbord, LF Fried, MK Mor, AL Resnick, ML Unruh, PM Palevsky, et al.
Renal provider recognition of symptoms in patients on maintenance hemodialysis.
Clin J Am Soc Nephrol, 2 (2007), pp. 960-967
[46]
R Heslegrave, K Thornley, M Ouwendyk, R Francoeur, P Sumal, A Pierratos, P Hanly.
Impact of nocturnal hemodialysis on sleep and daytime cognitive functioning in patients with chronic renal failure.
Sleep, 21 (1998), pp. 1
[47]
WE Bloembergen, FK Port, EA Mauger, RA Wolfe.
A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis.
J Am Soc Nephrol, 6 (1995), pp. 184-191
[48]
A Noda, S Nakai, T Soga, T Sugiura, N Iwayama, K Maeda, et al.
Factors contributing to sleep disturbance and hypnotic drug use in hemodialysis patients.
Intern Med, 45 (2006), pp. 1273-1278
[49]
HK Yaggi, J Concato, WN Kernan, JH Lichtman, LM Brass, V Mohsenin.
Obstructive sleep apnea as a risk factor for stroke and death.
N Engl J Med, 353 (2005), pp. 2034-2041
[50]
T Mooe, KA Franklin, U Wiklund, T Rabben, K Holmström.
Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease.
Chest, 117 (2000), pp. 1597-1602
[51]
L Lavie.
Obstructive sleep apnoea syndrome – an oxidative stress disorder.
Sleep Med Rev, 7 (2003), pp. 35-51
[52]
EK Larkin, CL Rosen, HL Kirchner, A Storfer-Isser, JL Emancipator, NL Johnson, et al.
Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration.
Circulation, 111 (2005), pp. 1978-1984
[53]
L Lavie.
Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach.
Neurol Clin, 23 (2005), pp. 1059-1075
[54]
AF Charest, PJ Hanly, RK Parkes.
Impact of sleep apnea on mortality in patients with end-stage renal disease.
J Am Soc Nephrol, 15 (2004), pp. 637A
[55]
J Beecroft, J Duffin, A Pierratos, CT Chan, P McFarlane, PJ Hanly.
Enhanced chemo-responsiveness in patients with sleep apnoea and end-stage renal disease.
Eur Respir J, 28 (2006), pp. 151-158
[56]
GE Anastassov, N Trieger.
Edema in the upper airway in patients with obstructive sleep apnea syndrome.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 86 (1998), pp. 644-647
[57]
JW Shepard Jr, DA Pevernagie, AW Stanson, BK Daniels, PF Sheedy, et al.
Effects of changes in central venous pressure on upper airway size in patients with obstructive sleep apnea.
Am J Respir Crit Care Med, 153 (1996), pp. 250-254
[58]
KL Chiu, CM Ryan, S Shiota, P Ruttanaumpawan, M Arzt, JS Haight, et al.
Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects.
Am J Respir Crit Care Med, 174 (2006), pp. 1378-1387
[59]
MR Pressman, RL Benz, CR Schleifer, DD Peterson.
Sleep disordered breathing in ESRD: acute beneficial effects of treatment with nasal continuous positive airway pressure.
Kidney Int, 43 (1993), pp. 1134-1139
[60]
A Loewen, A Siemens, PJ Hanly.
Sleep quality in patients with end-stage renal disease: contribution of sleep apnea and periodic leg movements.
Am J Respir Crit Care Med, 117 (2008), pp. A936
[61]
SC Tang, B Lam, PP Ku, WS Leung, CM Chu, YW Ho, et al.
Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis.
J Am Soc Nephrol, 17 (2006), pp. 2607-2616
[62]
JM Beecroft, J Zaltzman, R Prasad, G Meliton, PJ Hanly.
Impact of kidney transplantation on sleep apnoea in patients with end-stage renal disease.
Nephrol Dial Transplant, 22 (2007), pp. 3028-3033
[63]
G Merlino, A Piani, P Dolso, M Adorati, I Cancelli, M Valente, et al.
Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy.
Nephrol Dial Transplant, 21 (2006), pp. 184-190
[64]
CJ Eichel.
Stress and coping in patients on CAPD compared to hemodialysis patients.
ANNA J, 13 (1986), pp. 9-13
[65]
AE Molzahn, HC Northcott, JB Dassetor.
Quality of life of individuals with end stage renal disease: perceptions of patients, nurses and psysicians.
ANNA J, 24 (1997), pp. 325-333
[66]
RM Friedrich.
Patient perception of distress associated with hemodialysis: a state survey.
J Am Assoc Nephrol Nurses Tech, 7 (1980), pp. 252-258
[67]
PS Parfrey, HM Vavasour, S Henry, M Bullock, MH Gault.
Clinical features and severity of nonspecific symptoms in dialysis patients.
Nephron, 50 (1988), pp. 121-128
[68]
R Daley, C Hassall.
Reported sleep maintenance on haemodialysis.
Br Med J, 2 (1970), pp. 508-509
[69]
R Hays, J Kallich, D Mape, S Coons, W Carter.
Development of the kidney disease quality of life (KDQOL) instrument.
Qual Life Res, 3 (1994), pp. 329-338
[70]
LG Hart, RW Evans.
The functional status of ESRD patients as measured by the Sickness Impact Profile.
J Chronic Dis, 40 (1987), pp. 117S-136S
[71]
VK Somers, DP White, R Amin, WT Abraham, F Costa, A Culebras, et al.
Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing.
J Am Coll Cardiol, 52 (2008), pp. 686-717
[72]
Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.
Circulation, 93 (1996), pp. 1043-1065
[73]
RE Kleiger, JP Miller, JT Bigger Jr, AJ Moss.
Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.
Am J Cardiol, 59 (1987), pp. 256-262
[74]
HL Chica, F Escobar, J Eslava.
Validación de la Escala de Somnolencia de Epworth. Rev.
Salud Pública, 9 (2007), pp. 558-567
Conflictos de interés: los autores no reportan conflictos de interés en este artículo.
Copyright © 2010. Asociación Colombiana de Psiquiatría
